# A Narrative Review: A1 and A2 Milk Beta Caseins Effect on Gut Microbiota

**Authors:** Sathya Sujani, Klaudia J. Czerwinski, Dennis A. Savaiano

PMC · DOI: 10.3390/nu18010138 · Nutrients · 2026-01-01

## TL;DR

This review explores how A1 and A2 milk proteins affect gut bacteria, suggesting A2 may be better for gut health.

## Contribution

The paper systematically compares the effects of A1 and A2 beta casein on gut microbiota and highlights the need for human studies.

## Key findings

- A1 beta casein is more often linked to gut dysbiosis and pathogenic bacteria.
- A2 beta casein promotes microbial diversity and gut health.
- Effects are more pronounced in immunosuppressed individuals.

## Abstract

Background/Objectives: The composition and function of gut microbiome is significantly influenced by dietary factors. Growing evidence suggests that A1-type and A2-type beta casein (β-CN) may exert distinct effects on the gut environment, with implications for digestive discomfort and broader health outcomes. This review summarizes current evidence on how milk-derived A1 and A2 β-CN affect the gut microbiota. Methods: We conducted a literature search using PubMed, Web of Science, and Scopus to identify studies examining effects of milk β-CN on gut microbiota. Results: A total of eight studies were included. Results show inconsistencies within the limited number of studies. However, compared to A2, A1 β-CN was more frequently associated with dysbiosis and an increased abundance of potentially pathogenic species. Conversely, A2 β-CN promoted microbial diversity, which is linked to improved gut integrity and metabolic health. Conclusions: These findings suggest that β-CN variants distinctly influence the gut microbiota composition, and results were more significant in immunosuppressed subjects or those with other underlying health conditions, indicating that dairy products rich in A2 β-CN may offer advantages in personalized dietary management. However, well-designed human studies are essential to translate findings from rodent models to clinically relevant outcomes and future research should focus on mechanistic exploration and population-specific responses.

## Full-text entities

- **Genes:** CSN2 (casein beta) [NCBI Gene 1447] {aka CASB, PDC213}
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12787390/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12787390/full.md

## References

63 references — full list in the complete paper: https://tomesphere.com/paper/PMC12787390/full.md

---
Source: https://tomesphere.com/paper/PMC12787390